| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093621 Scgb3a2 as a growth factor and anti-apoptotic agent |
| 04/15/2010 | US20100092579 Medicament for treating lung cancer |
| 04/15/2010 | US20100092569 Product based on conjugated linoleic acid and a method for the manufacture thereof |
| 04/15/2010 | US20100092562 Sustained-release drug delivery compositions and methods |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092472 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
| 04/15/2010 | US20100092462 Methods for Suppressing Toll-Like Receptor Activity |
| 04/15/2010 | US20100092449 Treatment of Pompe's Disease |
| 04/15/2010 | US20100092402 Treatment of respiratory disease |
| 04/15/2010 | US20100092397 Method For Treatment of COPD and Other Pulmonary Diseases |
| 04/15/2010 | CA2742902A1 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer |
| 04/15/2010 | CA2739893A1 Inhalation of levofloxacin for reducing lung inflammation |
| 04/15/2010 | CA2739353A1 Corticosteroid compositions and methods of treatments thereof |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174665A2 Compositions and methods for activating innate and allergic immunity |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2174139A1 Method for testing a subject thought to have or to be predisposed to asthma |
| 04/14/2010 | EP2173730A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates |
| 04/14/2010 | EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1994277B Solid preparation of salvianolic acid A of red sage root and preparation process thereof |
| 04/14/2010 | CN1899357B Method for producing persimmon frost medicine |
| 04/14/2010 | CN1739655B Quality control method of Qingkailing injection preparation |
| 04/14/2010 | CN101693865A Mulberry leaf pure wine and production process thereof |
| 04/14/2010 | CN101693089A Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof |
| 04/14/2010 | CN101693081A Traditional Chinese medicine composition for treating pig pyretic pulmonary disease and method for preparing the composition |
| 04/14/2010 | CN101693077A Medicament for treating febrile bronchial asthma and chronic bronchitis |
| 04/14/2010 | CN101693058A Medicament for preventing and treating cold and inflammation infection |
| 04/14/2010 | CN101693054A Ginseng root compound preparation for clearing lung-heat and preparation method thereof |
| 04/14/2010 | CN101693051A Preparation method and composition of clerodendranthus spicatus extract |
| 04/14/2010 | CN101693010A Cefathiamidine prosoma liposome preparation |
| 04/14/2010 | CN101152379B Traditional Chinese medicine for treating cough and technique of preparing the same |
| 04/14/2010 | CN101129353B Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket |
| 04/14/2010 | CN101032598B Expectorant cough suppressant and anti-asthmatic healthy wine |
| 04/13/2010 | US7696357 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders |
| 04/13/2010 | US7696324 Humanized antibodies |
| 04/13/2010 | US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | CA2443802C Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/13/2010 | CA2321268C Liquid crystal forms of cyclosporin |
| 04/13/2010 | CA2293484C Dispenser with doses counter |
| 04/08/2010 | WO2010040054A2 Methods for suppressing toll-like receptor activity |
| 04/08/2010 | WO2010039982A1 Crth2 modulators |
| 04/08/2010 | WO2010039977A2 Heteroaryl antagonists of prostaglandin d2 receptors |
| 04/08/2010 | WO2010039260A2 Spiperone derivatives and methods of treating disorders |
| 04/08/2010 | WO2010039079A1 Isoquinolinone derivatives |
| 04/08/2010 | WO2010038434A1 Process for production of optically active hexahydropyrroloquinoline and intermediate for the process |
| 04/08/2010 | WO2010037179A1 Anionic conjugates of glycosylated bacterial metabolite |
| 04/08/2010 | US20100087515 Ikk-beta serine-threonine protein kinase inhibitors |
| 04/08/2010 | US20100087476 Pharmaceutical compounds |
| 04/08/2010 | US20100087475 Pharmaceutical compounds |
| 04/08/2010 | US20100087443 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators |
| 04/08/2010 | US20100087435 Modulators of atp-binding cassette transporters |
| 04/08/2010 | US20100087416 Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| 04/08/2010 | US20100087410 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 04/08/2010 | US20100087374 Methods for Treatment and Diagnosis of Pulmonary Diseases Based on the Expression of SERCA2 Protein |
| 04/08/2010 | US20100086615 Agent for treatment of pulmonary disease |
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | CA2739083A1 Methods for suppressing toll-like receptor activity |
| 04/08/2010 | CA2739050A1 Antibodies against il-25 |
| 04/08/2010 | CA2738828A1 Novel compounds |
| 04/08/2010 | CA2738827A1 P38 mapk kinase inhibitors |
| 04/08/2010 | CA2737434A1 Isoquinolinone derivatives |
| 04/07/2010 | EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor |
| 04/07/2010 | EP2172468A1 Benzimidazolone compounds |
| 04/07/2010 | EP2172458A1 Pyrazolone derivative |
| 04/07/2010 | EP2172217A1 Fibrosis inhibitor |
| 04/07/2010 | EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 04/07/2010 | EP2170932A1 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith |
| 04/07/2010 | EP2170901A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 04/07/2010 | EP2170895A1 Sildenafil n-oxide as prodrug |
| 04/07/2010 | EP2170848A1 Pyrazinone derivatives and their use in the treatment of lung diseases |
| 04/07/2010 | EP2170841A1 Process for introduction of hydroxyethoxy side chain in bosentan |
| 04/07/2010 | EP2170838A1 Particulates of a crth2 antagonist |
| 04/07/2010 | EP2170828A1 Substituted n-aryl pyridinones as fibrotic inhibitors |
| 04/07/2010 | EP2170825A2 Substituted indoles |
| 04/07/2010 | EP2170280A2 An inhalable composition comprising nicotine |
| 04/07/2010 | EP2170065A1 Diphenyl substituted alkanes |
| 04/07/2010 | EP1583559B1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 04/07/2010 | EP1431275B1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | CN1985967B Medicine for treating chronic bronchitis and bronchial asthma and its preparing method |
| 04/07/2010 | CN101690788A Throat-clearing three dispersion granules |
| 04/07/2010 | CN101690773A Method for detecting quality of cough stopping syrup |
| 04/07/2010 | CN101690758A Compound datura flower asthma relieving powder for treating respiratory tract infection of pigs and preparation method thereof |
| 04/07/2010 | CN101690757A Method for preparing bezoar supernatant preparations |
| 04/07/2010 | CN101690745A Chinese medicinal composition for preventing and treating flu |
| 04/07/2010 | CN101690732A Rana chensinensis egg oil health care product and preparation method thereof |
| 04/07/2010 | CN101690729A Application of montmorillonite in preparing medicament |
| 04/07/2010 | CN101690584A Functional food and medicine for clearing throat and preparation method thereof |
| 04/07/2010 | CN101156636B A seal wort and lily pure and fresh tea |
| 04/07/2010 | CN101015698B Medicament using rare earth transferring complex compound as vector |